{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:16:32Z","timestamp":1787015792259,"version":"build-2736575974"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":3139,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cutaneous plasmacytosis (CP) is a syndrome of multiple cutaneous plasma cell tumors, in the absence of multiple myeloma. Although rare in both humans and dogs, treatment recommendations are usually extrapolated from multiple myeloma protocols. To date, no case series of CP have been described in the veterinary literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis\/Objectives<\/jats:title>\n                    <jats:p>To describe clinical presentation, determine treatment response rates and duration, and report overall survival of dogs with CP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Twenty-one client-owned dogs with CP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Medical records of 21 dogs with CP were reviewed. Diagnosis was based on histopathologic evaluation of at least 1 representative cutaneous or subcutaneous lesion in dogs with \u22653 lesions. Dogs with suspicion of multiple myeloma were excluded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The most commonly affected breeds were the golden (5\/21) and Labrador retriever (3\/21). Fourteen of 21 dogs had &amp;gt;10 lesions, with some having &amp;gt;100. Lesions commonly were described as round, raised, pink-to-red, and variably alopecic or ulcerated. The most commonly used drug protocol was combined melphalan and prednisone, with an overall response rate (ORR) of 73.7% (14\/19 dogs). Single-agent lomustine was associated with a similar ORR of 71.4% (5\/7 dogs). For all treatments combined, the median progression-free interval after the first treatment was 153 days. The median survival time from the first treatment was 542 days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>Alkylating agents were effective in inducing remission of CP; corticosteroids, melphalan, and lomustine were the most commonly used drugs. Survival times were similar to those reported in dogs with multiple myeloma treated with alkylating agents.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.14729","type":"journal-article","created":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T11:56:59Z","timestamp":1495022219000},"page":"1074-1080","source":"Crossref","is-referenced-by-count":29,"title":["Canine Cutaneous Plasmacytosis: 21 Cases (2005\u20132015)"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4994-1920","authenticated-orcid":false,"given":"B.O.","family":"Boostrom","sequence":"first","affiliation":[{"name":"Colorado State University Flint Animal Cancer Center , Fort Collins, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.S.","family":"Moore","sequence":"additional","affiliation":[{"name":"Veterinary Oncology Consultants , Lake Innes, NSW,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.","family":"DeRegis","sequence":"additional","affiliation":[{"name":"Pieper Memorial Veterinary Center , Middletown, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Robat","sequence":"additional","affiliation":[{"name":"University of Wisconsin Veterinary Medical Teaching Hospital , Madison, WI"},{"name":"Veterinary Specialty Center , Middleton, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Freeman","sequence":"additional","affiliation":[{"name":"Veterinary Cancer and Surgery Specialists , Milwaukie, OR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8914-7767","authenticated-orcid":false,"given":"D.H.","family":"Thamm","sequence":"additional","affiliation":[{"name":"Colorado State University Flint Animal Cancer Center , Fort Collins, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,7,1]]},"reference":[{"key":"2026020303200364100_jvim14729-bib-0001","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1748-5827.1987.tb05970.x","article-title":"Primary cutaneous plasmacytomas in the dog and cat","volume":"28","author":"Lucke","year":"1987","journal-title":"J Small Anim Pract"},{"key":"2026020303200364100_jvim14729-bib-0002","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2460\/javma.1989.194.06.803","article-title":"Mucocutaneous plasmacytomas in dogs: 75 cases (1980\u20131987)","volume":"6","author":"Rakich","year":"1989","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303200364100_jvim14729-bib-0003","first-page":"105","article-title":"Extramedullary plasmacytomas in dogs: Results of surgical excision in 131 cases","volume":"28","author":"Clark","year":"1992","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020303200364100_jvim14729-bib-0004","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1439-0442.2002.00456.x","article-title":"Clinico-pathological aspects of canine cutaneous and mucocutaneous plasmacytomas","volume":"49","author":"Cangul","year":"2002","journal-title":"J Vet Med A Physiol Pathol Clin Med."},{"key":"2026020303200364100_jvim14729-bib-0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5326\/0440075","article-title":"Survival data for canine oral extramedullary plasmacytoma: A retrospective analysis (1996\u20132006)","volume":"44","author":"Wright","year":"2008","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020303200364100_jvim14729-bib-0006","first-page":"665","article-title":"Withrow and MacEwen's Small Animal Clinical Oncology","author":"Vail","year":"2007","edition":"5"},{"key":"2026020303200364100_jvim14729-bib-0007","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jaad.2012.11.031","article-title":"Cutaneous plasmacytosis: Report of 6 cases with or without systemic involvement","volume":"68","author":"Honda","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"2026020303200364100_jvim14729-bib-0008","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.clml.2011.07.004","article-title":"Cutaneous and systemic plasmacytosis vs. cutaneous plasmacytic castleman disease: Review and speculations about pathogenesis","volume":"11","author":"Haque","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2026020303200364100_jvim14729-bib-0009","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2133.1992.tb14827.x","article-title":"Systemic and cutaneous plasmacytosis with multiple skin lesions and polyclonal hypergammaglobulinaemia: Significant serum interleukin-6 levels","volume":"127","author":"Kodama","year":"1992","journal-title":"Br J Dermatol"},{"key":"2026020303200364100_jvim14729-bib-0010","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00000372-199706000-00016","article-title":"Case of malignant lymphoma associated with primary systemic plasmacytosis with polyclonal hypergammaglobulinemia","volume":"19","author":"Nitta","year":"1997","journal-title":"Am J Dermatopathol"},{"key":"2026020303200364100_jvim14729-bib-0011","first-page":"265","article-title":"Skin Tumors of the Dog and Cat","author":"Goldschmidt","year":"1992"},{"key":"2026020303200364100_jvim14729-bib-0012","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/vco.12032","article-title":"Response evaluation criteria for solid tumours in dogs (v1.0): A Veterinary Cooperative Oncology Group (VCOG) consensus document","volume":"13","author":"Nguyen","year":"2015","journal-title":"Vet Comp Oncol"},{"key":"2026020303200364100_jvim14729-bib-0013","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/vco.283","article-title":"Veterinary Cooperative Oncology Group \u2013 common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.1","volume":"14","year":"2016","journal-title":"Vet Comp Oncol"},{"key":"2026020303200364100_jvim14729-bib-0014","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0021-9975(89)90103-5","article-title":"An immunohistochemical study of canine extramedullary plasma cell tumors","volume":"100","author":"Kyriazidou","year":"1989","journal-title":"J Comp Pathol"},{"key":"2026020303200364100_jvim14729-bib-0015","first-page":"125","article-title":"Prognostic value of histopathological grading in canine extramedullary plasmacytomas","volume":"28","author":"Platz","year":"1991","journal-title":"Vet Pathol"},{"key":"2026020303200364100_jvim14729-bib-0016","first-page":"1161","article-title":"Cutaneous and systemic plasmocytosis","volume":"11","author":"Wagner","year":"2013","journal-title":"J Dtsch Dermatol Ges"},{"key":"2026020303200364100_jvim14729-bib-0017","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.2460\/javma.239.11.1477","article-title":"Monoclonal immunoglobulin protein production in two dogs with secretory B-cell lymphoma with Mott cell differentiation","volume":"239","author":"Seelig","year":"2011","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303200364100_jvim14729-bib-0018","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1365-2133.1998.02206.x","article-title":"Systemic plasmacytosis with deposition of interleukin (IL)-6 and elevated expression of IL-6 mRNA in the skin lesions","volume":"138","author":"Kanbe","year":"1998","journal-title":"Br J Dermatol"},{"key":"2026020303200364100_jvim14729-bib-0019","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1200\/JCO.1994.12.4.759","article-title":"High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma","volume":"12","author":"Cunningham","year":"1994","journal-title":"J Clin Oncol"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvim.14729","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/31\/4\/1074\/66669021\/jvim14729.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/31\/4\/1074\/66669021\/jvim14729.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T08:20:11Z","timestamp":1770106811000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/31\/4\/1074\/8449466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,1]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.14729","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,7]]},"published":{"date-parts":[[2017,7,1]]}}}